Suzhou MedicalSystem Technology Co Ltd develops medical engineering technology and promotes clinical system for operation theatre and intensive care units.
2009
2.0K+
LTM Revenue n/a
LTM EBITDA n/a
$718M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MedicalSystem Technology has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, MedicalSystem Technology achieved revenue of $85.2M and an EBITDA of -$24.8M.
MedicalSystem Technology expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See MedicalSystem Technology valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $85.2M | n/a | XXX | XXX | XXX |
Gross Profit | $34.0M | $29.7M | XXX | XXX | XXX |
Gross Margin | 40% | NaN% | XXX | XXX | XXX |
EBITDA | -$24.8M | n/a | XXX | XXX | XXX |
EBITDA Margin | -29% | NaN% | XXX | XXX | XXX |
Net Profit | $5.8M | $4.6M | XXX | XXX | XXX |
Net Margin | 7% | NaN% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MedicalSystem Technology's stock price is CNY 13 (or $2).
MedicalSystem Technology has current market cap of CNY 3.9B (or $542M), and EV of CNY 5.2B (or $718M).
See MedicalSystem Technology trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$718M | $542M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MedicalSystem Technology has market cap of $542M and EV of $718M.
MedicalSystem Technology's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate MedicalSystem Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MedicalSystem Technology and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $718M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMedicalSystem Technology's NTM/LTM revenue growth is n/a
MedicalSystem Technology's revenue per employee for the last fiscal year averaged $43K, while opex per employee averaged $22K for the same period.
Over next 12 months, MedicalSystem Technology's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MedicalSystem Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MedicalSystem Technology and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | n/a | XXX | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $43K | XXX | XXX | XXX | XXX |
Opex per Employee | $22K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
Opex to Revenue | 51% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedicalSystem Technology acquired XXX companies to date.
Last acquisition by MedicalSystem Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . MedicalSystem Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was MedicalSystem Technology founded? | MedicalSystem Technology was founded in 2009. |
Where is MedicalSystem Technology headquartered? | MedicalSystem Technology is headquartered in China. |
How many employees does MedicalSystem Technology have? | As of today, MedicalSystem Technology has 2.0K+ employees. |
Is MedicalSystem Technology publicy listed? | Yes, MedicalSystem Technology is a public company listed on SHG. |
What is the stock symbol of MedicalSystem Technology? | MedicalSystem Technology trades under 603990 ticker. |
When did MedicalSystem Technology go public? | MedicalSystem Technology went public in 2016. |
Who are competitors of MedicalSystem Technology? | Similar companies to MedicalSystem Technology include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of MedicalSystem Technology? | MedicalSystem Technology's current market cap is $542M |
Is MedicalSystem Technology profitable? | Yes, MedicalSystem Technology is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.